Concepedia

Davinder Dosanjh

DD

Statistics

Publications

30

Citations

4.6K

H-Index

23

Active since

2004

Affiliations

University of Birmingham(Current)

University Hospitals Birmingham NHS Foundation Trust

University of Oxford

Imperial College London

University of Southampton

Davinder Dosanjh is an author at University of Birmingham specializing in medicine, immunology, and infectious diseases.

Publications per year

2004–2024

30

Publications

30

Azithromycin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial

Eugenia Abaleke, Mustafa Abbas, Sadia Abbasi et al. · The Lancet · 2021 · 564 citations · Full text

Pharmacy, Infectious Diseases, Pharmacotherapy +6

Convalescent plasma in patients admitted to hospital with COVID-19 (RECOVERY): a randomised controlled, open-label, platform trial

Obbina Abani, Ali Abbas, Fatima Abbas et al. · The Lancet · 2021 · 521 citations · Full text

Pharmacy, Internal Medicine, Pharmacotherapy +11

Safety and efficacy of inhaled nebulised interferon beta-1a (SNG001) for treatment of SARS-CoV-2 infection: a randomised, double-blind, placebo-controlled, phase 2 trial

Phillip Monk, Richard Marsden, Victoria Tear et al. · The Lancet Respiratory Medicine · 2020 · 455 citations · Full text

Pharmacy, Infectious Diseases, Pharmacotherapy +10

Effect of Noninvasive Respiratory Strategies on Intubation or Mortality Among Patients With Acute Hypoxemic Respiratory Failure and COVID-19

Gavin D. Perkins, Chen Ji, Bronwen Connolly et al. · JAMA · 2022 · 414 citations · Full text

Medicine, Respiratory Therapy, Critical Care Respiratory Therapy +16

Casirivimab and imdevimab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial

Obbina Abani, Ali Abbas, Fatima Abbas et al. · The Lancet · 2022 · 384 citations · Full text

Life Sciences, Immunology, Pharmacotherapy +14

1–5 of 30